Handbook of Pharmaceutical Biotechnology 2006
DOI: 10.1002/9780470117118.ch1c
|View full text |Cite
|
Sign up to set email alerts
|

Overview: Differentiating Issues in the Development of Macromolecules Compared with Small Molecules

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
9
0

Year Published

2010
2010
2019
2019

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 13 publications
(9 citation statements)
references
References 0 publications
0
9
0
Order By: Relevance
“…Therapeutic small molecules (< 1000 Da) have unique advantages over and are an important alternative to growth factors (5, 6) (7). Small molecules are unlikely to induce an immune response in the host because they are too small to do so (8). Unlike polypeptides, higher order structure is not a factor for small molecule function (9).…”
Section: Small Molecules In Regenerative Medicinementioning
confidence: 99%
“…Therapeutic small molecules (< 1000 Da) have unique advantages over and are an important alternative to growth factors (5, 6) (7). Small molecules are unlikely to induce an immune response in the host because they are too small to do so (8). Unlike polypeptides, higher order structure is not a factor for small molecule function (9).…”
Section: Small Molecules In Regenerative Medicinementioning
confidence: 99%
“…39 Small molecules' molecular size is also usually too small to induce unwanted immune responses in the host. 40 Small molecules, extensively used as chemotherapeutic agents for cancer treatment, have although some characteristics that limits their use in clinical applications, including hydrophobicity and nonspecific biodistribution and targeting. To overcome these limitations, the use of a biocompatible platform to localize and sustain the controlled release of small molecules to target sites has been proved to be advantageous.…”
Section: Introductionmentioning
confidence: 99%
“…For example, small molecules are unlikely to have any issues with immunogenicity because they are too small in size to stimulate an immune response [26]. Moreover, unlike protein growth factors, the bioactivities of small molecules usually do not require structural integrity [23,2729].…”
Section: Bone Growth Factorsmentioning
confidence: 99%